Online Webinars

Previous Webinars

Jun 5, 2019

Machine Learning for Automated Immune Profiling and Tumor Morphology Analysis on IF Images

A Comparison to TNM Staging in Bladder Cancer Machine and deep learning, key components of image analysis, enable the analysis of complex visual patterns. In this free webinar, the featured speakers will tackle the challenges of quantitative pathology and more specifically of immunofluorescence (IF) imaging, such as the variability of observed biological patterns, the...
View Full Event Post
May 31, 2019

Using AI Multiplex Biomarker Analysis for Deeper Insights into the Tumor Microenvironment

In this presentation, we will show examples of how histopathologic multiplexed immunohistochemistry (IHC) benefits from artificial intelligence and is used to a) gain a comprehensive understanding of Tumor Microenvironment (TME) heterogeneity, b) enhance current predictive/prognostic patient stratification and c) facilitate the development of novel biomarker signatures. Effective response to immunotherapy...
View Full Event Post
Jan 22, 2019

From Biomarkers to Companion Diagnostics:

In immuno-oncology, companion diagnostics are used in conjunction with targeted drugs and therapies to identify patients who are likely to benefit from a specific treatment regimen or who may have increased risk for certain side effects. Join this webinar for a discussion of the integration of digital pathology, clinical trial design and tissue-based...
View Full Event Post
Oct 9, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment

Summary: In this webinar, Dr. Rognoni describes the development of an automated workflow for quantitative analysis of multispectral immunofluorescence whole-tissue scans. This technique, developed at Definiens, allows the identification of spatial patterns for immunoprofiling, overcoming the limitation of small regions of interests and providing significant amount of data on the...
View Full Event Post
Sep 12, 2018

Tissue-based profiling for confident decisions in immuno-oncology

Summary This webcast highlights the benefits of standardizing tissue profiling for decision making in drug development and trial designs in immuno-oncology. Key topics include: Challenges in comparing results across different clinical studies that result from inconsistent biomarker strategies are discussed A harmonized tissue profiling strategy is introduced as a promising...
View Full Event Post